ABSTRACT
Vitamin A deficiency leads to an arrest of spermatogenesis and a loss of advanced germ cells in male mice. In the present study, the effects of several retinoids and carotenoids on these mouse testis were investigated.
First, the proliferative activity of the growth-arrested A spermatogonia in vitamin A-deficient (VAD) mice testis was determined, 20,24, or 28 h after administration of 0.5 mg all-trans-retinoic acid @A). The bromodeoxy-uridine (BrdU) labeling index of A spermatogonia in Control Vm teStiS was 5 5 1% (n = 4, mean t SD). When RA was injected (ip), the highest labeling index was found 24 h after RA administration:
49 ? 5%. When various concentrations of RA, all-truns-4-oxo-retinoic acid (4-0x0-R& or all-trans-retinol acetate (ROAc), ranging from 0.13-l mg, were injected, the labeling index of A spermatogonia always increased in comparison with the VAD situation.
A maximum index at 24 h was found when 0.5 mg I-0x0-RA was injected: 56 ? 3%. This labeling index was even higher than those after injection of RA or ROAc, 49 ? 5% and 34 ? 6% respectively. (Endocrinology 137: 479-485, 1996) I N THE seminiferous epithelium of vitamin A-deficient (VAD) mice, a depletion of germ cells occurs. Only Sertoli cells, type A spermatogonia, and occasionally a few degenerating spermatids are present (1). In normal mice, spermatogenesis starts with undifferentiated A spermatogonia (2,3), most of which differentiate into so called differentiating A, spermatogonia in epithelial stages VII-VIII. Subsequently, the remaining undifferentiated A spermatogonia start to proliferate to produce new differentiating A spermatogonia for the next epithelial cycle. The newly formed differentiating A, spermatogonia also start a series of divisions, leading to the formation of spermatocytes and ultimately to spermatids. The nature of the remaining A spermatogonia in the VAD testis is still a matter of debate. It is our working hypothesis that they are undifferentiated A spermatogonia, arrested in Gl phase, that are unable to differentiate into A, spermatogonia (4, 5). As in the rat (6-lo), spermatogenesis can be reinitiated by retinol administration in the mouse too, resulting in a synchronized formation of A, spermatogonia, which start to proliferate (1). RA, when given in high and frequent doses, is also able to restore spermatogenesis in the rat (11). Retinol and RA strongly stimulate the proliferative activity of A spermatogonia in VAD rats with the highest number of bromodeoxy-uridine (BrdU)-labeled A spermatogonia being present 30 h after administration (10, 11).
The effects of retinol and RA may either be direct on the A spermatogonia or indirect, possibly via Sertoli cells, which are known to produce various growth factors. Binding proteins or nuclear receptors may play an important role in mediating these effects. In the testis, both cellular retinol binding proteins (CRBPs) and cellular RA binding proteins (CRABI's) are present (12-17), as well as the nuclear RA receptors RAR (Y, p, y, and RXR (Y (15, (18) (19) (20) (21) . Retinoid status and retinoid administration were shown to effect the expression of some of these genes (20, 22, 23) .
RA and 9-cis-RA are considered to be ligands for the RARs.
However, the discovery that 9-cis-RA is also the ligand for the very related retinoid receptor family, the RXRs (24-26), led to a renewed interest in other retinoids. All-trans-4-0x0-retinoic acid (4-0x0-RA), first considered to be an inactive metabolite of RA during growth and differentiation (27), was recently shown to be highly active in modulating the positional specification in early Xenopus embryos (28). Furthermore, 4-0x0-RA binds to and activates RARB with an affinity similar to that of RA (28). Kim et al. (29) have also shown that, when compared with RA, the binding activities of 4-0x0-RA to recombinant RARs is equal for RARa and RARP, and just slightly less for RARy. However, in a number of in vitro growth and differentiation assays, 4-oxo-RA seemed to have a lower activity than RA (27, 28, 30) . In contrast, Nikawa et al. (311 found RA and 4-0x0-RA to be equipotent in inducing cell differentiation of a F9 reporter cell line, containing the RARP2 promoter coupled to the 1acZ reporter gene. We now have compared the in vizlo effects of retinol, RA, 4-0x0-RA, and the dimers of RA and 4-oxo-RA, p-carotene (PC), and canthaxanthin (CTX), respectively, on the differentiation of the undifferentiated A spermatogonia into A, spermatogonia in the VAD mouse testis. It is shown that 4-0x0-RA is at least as potent as RA in the induction of the differentiation of A spermatogonia and the subsequent proliferation of these spermatogonia in vivo. At several time intervals after RA administration, animals were killed by CO? (at least four animals at each time point).
Materials and Methods

Animals
In Exp 2, all VAD animals were injected with different concentrations of RA, 4-0x0-RA, retinolacetate, PC, or canthaxanthin fin 16% DMSO/ H,O, except for the 1 mg quantities, which were dissolved in 32% DMSO/H,O).
Twenty-four hours after retinoid administration, all animals were killed by CO2 (at least 4 animals per group). In Exp 3, VAD mice were injected (ip) with a single dose of 0.5 mg /3C or with 1 mg PC (in 18% DMSO/H,O) twice a week. Animals were killed by CO1 10.5 days after the first injection.
In Exp 4, VAD mice were injected (ip) with 1 mg /3C (in 18% DM'SO/ H,O). Animals were killed 1,2,3, or 4 days after retinoid administration by CO, (4 animals per group). In Exp 5, VAD mice were injected with 1 mg RA (in 32% DMSO/H,O). Animals were killed 20 h after RA administration by CO,. All animals in Exps 1,2,4, and 5 received an ip injection of 5-BrdU (100 mg/kg BW, Sigma, St. Louis, MO) 2 h before they were killed. During all experiments, animals remained on the VAD diet.
Retinoids
Retinol acetate, all-trans-RA, and all-truns-p-carotene were purchased from Sigma. 
Results
Maximum BrdU labeling of A spermatogonia
Because the cell cycle times of spermatogonia in the mouse are shorter than those in the rat (33-35), it was necessary to determine the time of maximum S phase activity of A spermatogonia in the VAD mouse after vitamin A replacement. Because in VAD rats this maximum occurs at 30 h after vitamin A replacement (lo), this was done by studying the BrdU-incorporation at 20, 24, or 28 h after RA injection. When only solvent was administered to VAD mice, the labeling index was 5 + 1%. When 0.5 mg of RA was given, the percentage of labeled A spermatogonia increased significantly (P < 0.01, Fig. 1 ). The highest labeling index of A spermatogonia was found 24 h after administration of RA: 49 t 5%.
Labeling indices of A spermatogonia after administration of various retinoids and carotenoids
The BrdU labeling indices of A spermatogonia in VAD mice were determined 24 h after administration of various concentrations of RA, 4-0x0-RA, retinolacetate, all-tmns-p-carotene, or canthaxanthin. After administration of R4, 4-0x0&4 or retinolacetate the percentage of BrdU-labeled A spermatogonia significantly increased above the VAD level (P < 0.01, Fig. 2) . Surprisingly, the highest labeling indices were always found when 4-0x0-RA was injected, except at the lowest dose. Injection of 0.5 mg 4-0x0-RA resulted in a maximum index of 56 t 3%, compared with 49 2 5% when 0.5 mg RA was given. In comparison with R4 and 4-0x0&4, a significantly (P < 0.01) smaller increase in labeling index was found when 0.5 mg retinolacetate was injected: 34 2 6%. Furthermore, the effects of the retinoids on the proliferative activity of A sper- matogonia proved to be dose dependent. After an initial increase of the labeling indices with increasing retinoid concentration, the labeling indices decreased at a higher concentration. When 0.5 mg canthaxanthin or PC was injected, a labeling index equal to the VAD value was found (respectively, 6 -C 1% and 4 ? 0.1%).
Effects of PC administration to VAD mice Because administration of 0.5 mg of PC had no effect on the proliferative activity of A spermatogonia in VAD mice 24 h after injection (Fig. l) , we decided to study the effects of PC in more detail on a longer time scale.
In accordance with this unchanged labeling index, no formation of B spermatogonia or spermatocytes was found 10.5 days after administration of a single dose of 0.5 mg PC to VAD mice (Fig. 3A) . The histology of the seminiferous epithelium of these testes was comparable with that of VAD mice (Fig. 3B) , only Sertoli cells and A spermatogonia being present. Subsequently, VAD mice were given injections of 1 mg PC (ip) twice a week. After this treatment, a synchronous reinitiation of spermatogenesis could be observed (Fig. 3C) . At 10.5 days after the first injection of PC, B spermatogonia and/or preleptotene spermatocytes were present in virtually all tubular cross-sections (Fig.  3C) , as in stages IV-VIII of the normal epithelium. In several tubuli, mitotic figures could be seen, presumably of B spermatogonia.
When the BrdU labeling indices of A spermatogonia in VAD mice were determined 1, 2, 3, or 4 days after administration of a single dose of 1 mg PC to VAD mice, a significant increase in the percentage of BrdU labeled A spermatogonia could only be observed after 3 and 4 days (P < 0.05). The labeling indices at these times were 11.1 + 3.0% and 10.8 ? 1.5%, respectively (Fig. 4) .
Effect of retinoid concentration on the moment of maximum BrdU-labeling
The fact that the BrdU-labeling index of A spermatogonia decreases at the highest retinoid dose (Fig. 2) and the fact that this labeling index increases only slightly, with a delay of 2 days, after equimolar PC administration (Fig. 41, suggested to us that the optimum of BrdU labeling may be influenced by the testicular concentration of an active retinoid, not only quantitatively but also in time. This would mean that when a higher concentration of a certain retinoid was administered, a possible testicular threshold concentration could be reached sooner. The maximum of BrdU incorporation then would also occur sooner.
To test this hypothesis, VAD mice received 1 mg RA at t = 0 and BrdU at t = 18 or 22 h, after which they were killed at t = 20 or 24 h, respectively. The BrdU-labeling indices of the A spermatogonia of these mice were 65.8 2 1.3% and 33.3 ? 2.4%, respectively. When 0.5 mg RA was injected, these values were 36.9 2 4.3% and 48.5 ? 4.7%, respectively (Figs. 1 and 2 ). This means that at a higher retinoid concentration the optimum of BrdU labeling shifts to an earlier time and, furthermore, that this optimum is higher. 
Discussion
The present results confirm our previous finding that, as in the VAD rat, a synchronous reinitiation of spermatogenesis can be induced by administration of retinol in the VAD mouse (1,lO) . Furthermore, it is shown that, as in the rat (ll), in the mouse too RA is at least as effective as retinol in accomplishing this effect. The timing of the first peak of S phase cells is somewhat earlier than in the rat [24 h ~0s. 30 h (ll)], which is in accordance with the shorter cell cycle times of spermatogonia in the mouse (33-35).
The present results show for the first time an in viva effect of 4-oxo-RA in adult mammals. This metabolite is at least as potent as all-tuans-RA itself in the induction of differentiation and subsequent proliferation of growtharrested A spermatogonia. Because the molecular weights of retinolacetate, RA, and 4-oxo-RA are similar, indicating that equimolar quantities of these retinoids were used, the apparent order of activity, 4-oxo-RA>RA > all-tvans-retinol acetate (ROAc), seems to reflect their effectiveness in vivo.
In accordance with the in vivo data presented in this paper, Gratas et al. (36) and Nikawa et al. (31) found equal activities of RA and 4-0x0%4 on CFU-GM colony formation in bone marrow cells in vitro and on induction of cell differentiation of a F9 reporter cell line, containing the RARP2 promoter coupled to the IacZ reporter gene, respectively. Moreover, 4-0x0%4 binds to and activates RARs with an affinity similar to RA (28, 29, 36) . The affinity for CRABPI and II again is equal for both retinoids (37). These data seem to favour equal activities of RA and 4-oxo-RA. It is, however, still possible that retinoids have cell type-or tissue-specific activities because in a number of in vitro growth and differentiation assays the activity of 4-0x0%4 seems lower than that of RA (27, 28, 30) .
There is one striking difference between RA and 4-0x0-RA that may be of importance. It was shown that CRABPI has a retinoid specific effect on the rate of metabolism of these retinoids (38). The elimination time t,,, of free RA is 35 min and that of CRABPI-bound RA 40 min. t,,, of free 4-oxo-RA is 9 min. In contrast, binding of 4-0x0-RA to CRABPI almost completely abolishes metabolism: t,,, is estimated to be 630 min!
The possible presence of 4-oxo-RA in the testis was shown by Fiorella et al. (39) . When testis microsomes are incubated with RA, a number of polar metabolites, among which is 4-0x0&A, are formed. The amount found was low, less than 2% of the metabolites formed in such a testis microsomal incubation being 4-oxo-RA. However, the actual concentration of 4-oxo-RA in a cell may be much higher if a buffer of CRABP I-bound 4-0x0-RA is formed.
There may be multiple pathways of retinoid metabolism. Examples of such pathways are the oxidation of retinol to retinal by the cytosolic enzyme retinol dehydrogenase (40) and cytochrome P450-mediated 4-hydroxylation of retinol and RA (41). This hydroxylation results in the formation of more polar metabolites, among which is 4-0x0-RA. This metabolite can not be converted back to RA (41). High doses of vitamin A induce P450 activity (42).
In this paper, we have also shown that, at a given time, the effect of 4-oxo-RA, RA, and retinolacetate on the proliferative activity of A spermatogonia is concentration dependent with a certain maximum. The administered doses are comparable with those used in the VAD rat model (7, 8, 10) and are in the same order of magnitude as hepatic retinol stores in normal male animals (43-45). Normal circulating and testis retinoid levels are of course lower (45). At higher concentrations, the labeling index of the A spermatogonia decreased again. This phenomenon could both be caused by a toxic effect of high concentrations of retinoids or by a shift of the peak of maximal S phase activity of the A spermatogonia to an earlier time interval after administration of higher retinoid doses. The latter appeared to be the case. Because the curves found with the different retinoids in the dose response diagram (Fig. 2) are parallel over the complete concentration range tested, this timeshift seems to occur equally with all retinoids tested. Therefore, the conclusion about their efficacy, 4-oxo-RA>RA>ROAc, still seems to be valid. The slope of the curve in the dose response diagram may also be influenced by metabolism or transport. If metabolism to a more active retinoid is necessary, the curve may shift to higher concentrations and/or later times. The same holds for differences in the transport of the various retinoids. Because parallel curves for all retinoids are found, the difference in the activities of the retinoids seems influenced neither by metabolism nor by transport, unless these effects would counteract each other.
At a higher retinoid dose, the optimum of the labeling index of A spermatogonia not only occurs sooner but is also higher than at a lower dose. This means that more A spermatogonia are in S phase at the same time and thus that the reinitiation of spermatogenesis is more synchronized. It will be interesting to establish the optimum retinoid concentration to obtain a maximal synchronization effect on spermatogenesis. This can also lead to a more accurate estimate of the timepoint before the S phase at which the A spermatogonia are arrested.
The present results also show that PC is capable of inducing the differentiation and proliferation of A spermatogonia in VAD mice testis. A single dose of 0.5 mg PC did not induce the proliferation of A spermatogonia within 24 h or the formation of B spermatogonia or spermatocytes within 10.5 days. However, multiple injections of 1 mg PC did cause a synchronous reinitiation of spermatogenesis. These results somewhat resemble those found with RA in the rat (ll), where a single dose of RA did reinitiate spermatogenesis but where further development of the spermatogenic cells required high and replicate doses of RA. At 10.5 days after the first administration of PC, most tubular cross-sections were in stages IV-VIII. Compared with the reinitiation of spermatogenesis after retinolacetate administration
(1) this means that there is a lag period of 2-4 days. Concordantly, the BrdU labeling index of A spermatogonia after administration of 1 mg PC only significantly increased after 3 days, i.e. 2 days later than after injection of RA. In addition, compared with the labeling indices found with 0.5 mg RA, those found with 1 mg PC were much lower and the peak of BrdU labeling seemed less defined because increased labeling indices were found on two successive days. This indicates that the degree of synchronization of the seminiferous epithelium found after PC injection is less than that after RA administration.
For the biosynthesis of RA from PC, both central and excentric cleavage pathways have been proposed (46, 47) . The first produces two molecules of retinal, whereas the latter leads to series of /3-apo-carotenals of different chain length. The longer apo-carotenals can potentially be further converted to retinal, which can be reduced to yield retinol or oxidized to RA. This metabolism of PC may explain the slow and initially low increase in labeling index upon administration of PC to VAD mice. First, PC can be converted to a number of different metabolites, possibly resulting in a relatively low concentration of active metabolites. It may also be that enzymes involved in carotenoid metabolism are not present in sufficient amounts yet, analogous to the induction of cytochrome I'450 activity by vitamin A (42).
In conclusion, in this article it is shown for the first time that 4-oxo-RA is also active in adult mammals in vim and that 4-oxo-RA is at least as potent as RA in the induction of the proliferation of growth-arrested A spermatogonia in VAD mice testis. Furthermore, we have shown that the degree of sychronization of spermatogenesis is influenced by the retinoid dose. Carotenoids were shown to act in the induction of spermatogonial cell proliferation too but with a lower and delayed activity. The effects of carotenoids are probably mediated by chemical or enzymatical conversion to active products. The question of which of these retinoids is the most important metabolite in the testis needs further investigation. 
